Medical Marijuana in New York

Total Page:16

File Type:pdf, Size:1020Kb

Medical Marijuana in New York MEDICAL MARIJUANA IN NEW YORK: A Symposium Publication Following The Issues Into 2010 by The Committee on Drugs & the Law 1 Preface The Purpose of this Publication On February 7, 2007, the Committee on Drugs and the Law of the New York City Bar Association sponsored a Symposium on Medical Marijuana in New York. Most recently, the Committee has determined that the questions debated in 2007 about legalizing medical marijuana remain the same today. Those legal questions involve federalism, the Commerce Clause, the Supremacy Clause, free speech, and the Fifth Amendment right to life and due process. It is the Committee’s opinion that the conversation about medical marijuana should be promoted. The legal issues, which are often obscured by the medical issues, should be made public to be discussed and debated. This is particularly pertinent in New York State, as the New York State Legislature has not yet passed A. 9016 and S. 4041-B, the most recently proposed medical marijuana bills sponsored by Assemblymember Richard Gottfried and Senator Thomas Duane.1 In 2007, the purpose of the Symposium was three-fold: 1) to clarify the emerging legal issues caused by the passage of state-sponsored medical marijuana laws, in light of the federal prohibition against marijuana use; 2) to have the most recent medical marijuana bill before the New York State Assembly explained by the Assembly sponsor, Richard Gottfried; and 3) to create an interdisciplinary discussion about the legal and public health policy consequences of drug prohibition created by the federal Controlled Substance Act (the “CSA”). In 2010, the above stated medical marijuana agenda is still quite relevant, as the provisions of the CSA have not changed substantively since its inception. Presently, the CSA makes it difficult for: A) legitimate research on marijuana to be conducted, B) people with serious painful conditions to alleviate their pain, and C) doctors to provide appropriate treatment to patients without fear of losing their licenses and/or becoming the subject of a criminal investigation. 1 More recently, efforts have focused on the implementation of medical marijuana in New York State via its inclusion as an item in the FY 2011 Budget. Selena Ross, Support for Medical Marijuana Lights Up In State Senate, THE CAPITOL, Apr. 26, 2010, http://www.nycapitolnews.com/news/126/ARTICLE/1731/2010-04-26.html 2 Today, in 2010, New York State Assemblymember Richard Gottfried (D-75th District) and New York State Senator Thomas Duane (D-29th District) have their most recent versions of the medical marijuana bill pending before the New York State Legislature. They have offered identical bills (A. 9016 and S.4041-B, respectively), which have bi-partisan support. If passed, New York will become the 15th state to allow medical marijuana. As stated above, the Drugs and the Law Committee has chosen to publish this transcript now, as the questions debated in 2007, particularly about the Tenth Amendment and federalism, and the Fifth Amendment right to life, health and due process in the context of health care remain important concerns. Lawyers in general, legislators and citizens of states that have yet to pass a medical marijuana law, and who struggle with the pros and cons of joining this grassroots movement, will find this transcript highly informative. Once legislators decide to support medical marijuana, they must decide how to frame their legislation. This Symposium sheds light upon the legal and political issues at the core of these challenges. The New York City Bar Association has supported the availability of marijuana for medicinal use since 1997, just after Assemblymember Richard Gottfried offered his first bill to the New York State Legislature in 1996. Its support then, and now, is based upon substantial indicators that marijuana has medical utility, and the more recent revelation that the Drug Enforcement Administration (DEA) has declined to allow alternatives to the National Institute of Drug Abuse (NIDA) monopoly on supplying marijuana for research. The New York City Bar takes the position that freedom to conduct appropriate scientific research is vital to the welfare of the nation. The DEA’s administrative law judges have overturned their own agency’s decision regarding this contested policy, but compliance by the agency is voluntary. 2 The reader will, however, have an opportunity to duly consider a defense of the federal government’s position against medical marijuana by reading the words of the Committee’s honored colleague Edward Jurith of the White House’s Office of National Drug Control Policy. 2 See In the Matter of Lyle E. Craker, Ph.D., Opinion and Recommended Ruling, Findings of Fact, Conclusions of Law and Decision of the Administrative Law Judge, United States Department of Justice, Drug Enforcement Administration, Docket No. 05-16, February 12, 2007. 3 The Symposium In pursuit of this complex and very interesting conversation, Noah Potter, Esq., then-Chairperson of the Drugs and the Law Committee, was able to persuade a most outstanding set of panelists to join us in Manhattan for the Symposium. Mr. Potter began the Symposium, and discussed the Committee’s historical support for drug reform. He briefly discussed the array of social policies affected by American drug policy. Eric Sterling, President of the Criminal Justice Policy Foundation, Washington, D.C., and our moderator, introduced the history of marijuana’s medicinal use, and the development of our present day policies. Karen O’Keefe, then-Assistant Director for State Policy for the Marijuana Policy Project, Washington, D.C. (and now Director), presented a slide show of the medical marijuana laws presently in place, and how those laws are being enforced. Her slides are included. Her presentation highlighted the difficulty the federal government has had in executing federal law in those states that have legalized medical marijuana. Robert Raich, Attorney from Oakland, California, and Counsel to Respondent in the U.S. Supreme Court case Gonzales v. Raich3, gave a look at the deliberations of the U.S. Supreme Court in that case. He discussed the ONE question the Court agreed to consider, and reviewed the legal impact of all the issues not decided by the Supreme Court in that case. Edward Jurith, General Counsel of the Office of National Drug Control Policy, Washington, D.C., educated the audience about the U.S. Constitution and the powers vested in each branch of government. He revealed the political and legal reality behind existing federal law, and the power and authority Congress has to pursue the national interest of a united society. Susan Herman, Centennial Professor of Constitutional Law at Brooklyn Law School and General Counsel of the American Civil Liberties Union, continued the discussion about the U.S. Constitution, the role of Article II, and the complex process of constitutional decision-making. She explained to the audience as to how the medical marijuana legal discussion is a classic problem in federalism, and discussed how the federal government can enforce its laws in a state 3 Gonzales v. Raich, 545 U.S. 1 (2005) 4 without violating state sovereignty. Lastly, Assemblymember Richard Gottfried outlined the details of his 2007 medical marijuana bill4, and how it was designed to minimize exposure to the federal law. He also discussed the bi-partisan political support the bill had been attracting and its increased chances of being passed. Medical Marijuana in New York in 2010: It is important to note that A. 9016 is substantially different in content than A. 4867-B. A. 4867-B allowed certified patients and/or their caregivers to grow their own marijuana, and possess up to twelve plants, or up to 2.5 ounces of usable marijuana. A. 9016 allows marijuana to be produced and dispensed only through state certified organizations. This is designed to provide for the State’s capacity to monitor marijuana as it monitors other pharmaceuticals. However, under present day federal law, any organization or governmental entity engaging in the production or distribution of medical marijuana has no legal protection from the federal government and, theoretically, the assets of such businesses or entities could be seized by the federal government and the operator/owners criminally prosecuted. In October 2009, the Obama Administration’s U.S. Justice Department issued guidelines stating that the focus of federal resources should not be on individuals whose actions are in compliance with existing state laws in states that have passed medical marijuana legislation. 5 Concerns about marijuana’s prohibited status under federal law and diversion have influenced some New York State Senators to oppose the patient and caregiver production provision found in A. 4867-B. A. 9016 provides for “registered organizations,” defined as hospitals, pharmacies or non-profit entities, to produce and dispense marijuana, and allows certified patients and caregivers to possess up to 2.5 ounces of marijuana. The insistence on an external source of marijuana, as opposed to patient and caregiver production, is intended to make it easier for the government to monitor the distribution of marijuana, and to control diversion of the drug. In the interest of the health and welfare of the people of New York, the New York City Bar Association is committed to exploring the legal and policy considerations that 4 A. 4867-B, 2007 Leg., Reg. Sess. (N.Y. 2007) 5 The guidelines are at http://blogs.usdoj.gov/blog/archives/192 5 drive both sides of this conversation. Additionally, we look forward to the challenges that are likely to emerge. We recognize that both the individual states and the federal government will struggle with questions of federalism and human rights well into the 21st Century. The Association will continue to be a part of that struggle and that conversation. In closing, I must thank all the participants for donating their personal time and resources to the creation and success of this event.
Recommended publications
  • Drug Addiction Treatment and the Use of Criminal Sanctions
    IS IT TIME TO END THE WAR ON DRUGS? _______________________________________________________________________ AN EXAMINATION OF CURRENT LAW AND PRACTICE IN DRUG ABUSE PREVENTION, DRUG ADDICTION TREATMENT AND THE USE OF CRIMINAL SANCTIONS DECEMBER 2001 King County Bar Association Drug Policy Project 900 Fourth Avenue, Suite 600 Seattle, Washington 98164-1060 www.kcba.org Table of Contents King County Bar Association Drug Policy Statement Adopted by the Board of Trustees 5 Introduction 11 Conclusions and Recommendations 13 _______________________________________________________________________ SECTION I EFFECTIVE DRUG ABUSE PREVENTION: KEEPING OUR YOUTH OUT OF TROUBLE 1. Youth Involvement with Alcohol, Tobacco and Other Drugs 28 Current Trends in Washington and the Nation 28 Statistical Caution: Drug Use vs. Drug Abuse 29 Criminal Justice Contact – Increased Cost and Increased Harm 30 Opportunity for Cost Savings 31 2. Trying to Explain Juvenile Substance Abuse: 32 Risk Factors and Protective Factors Risk Factors 32 Protective Factors 34 Washington State Profile 34 Co-Occuring Behaviors and the “Gateway Theory” Fallacy 35 3. The Promise and Perils of Drug Abuse Prevention Programs 36 Changing Approaches to Prevention 36 The Failure of D.A.R.E. 37 Searching for Effective Prevention Programs 37 Finding the Key Elements 38 Measuring Use or Abuse? 39 4. Improving Washington’s Drug Abuse Prevention Strategy 41 Prevention Goals 41 1 Table of Contents (cont.) SECTION II DRUG ADDICTION TREATMENT: THE NEED FOR RESOURCES 1. Drug addiction is a source of serious and costly problems in Washington. 44 2. Society is justified in offering and, sometimes, in requiring drug addiction treatment. 46 3. Drug treatment should have multiple objectives.
    [Show full text]
  • Does the Constitution Apply to the Actions of the United States Anti-Doping Agency? Dionne L
    University of Baltimore Law ScholarWorks@University of Baltimore School of Law All Faculty Scholarship Faculty Scholarship Fall 2005 Does the Constitution Apply to the Actions of the United States Anti-Doping Agency? Dionne L. Koller University of Baltimore School of Law, [email protected] Follow this and additional works at: http://scholarworks.law.ubalt.edu/all_fac Part of the Constitutional Law Commons, and the Entertainment, Arts, and Sports Law Commons Recommended Citation Does the Constitution Apply to the Actions of the United States Anti-Doping Agency?, 50 St. Louis U. L.J. 91 (Symposium issue, 2005) This Article is brought to you for free and open access by the Faculty Scholarship at ScholarWorks@University of Baltimore School of Law. It has been accepted for inclusion in All Faculty Scholarship by an authorized administrator of ScholarWorks@University of Baltimore School of Law. For more information, please contact [email protected]. DOES THE CONSTITUTION APPLY TO THE ACTIONS OF THE UNITED STATES ANTI-DOPING AGENCY? DIONNE L. KOLLER* TABLE OF CONTENTS Page I. Introduction ....................................................................................................... 92 II. Background-Why and How USADA Was Created ....................................... 94 A. The Federal Government's Interest in Drugs and Sports ......................... 94 1. The Federal Government and the USOC ....................... '" .................. 94 2. The Fight Against Performance-Enhancing Drug Use in Amateur Sports .................................................................................. 96 3. The National Anti-Doping Strategy .................................................... 98 B. The Government's Efforts to Establish Domestic and International Anti-Doping Agencies ...................................................... 101 1. The Creation of the World Anti-Doping Agency ............................. 101 2. The Government's Role in Creating US ADA .................................. 105 C. Why USADA's Designation as a Private Entity is Important.
    [Show full text]
  • April 25-29,2009 Hiltonnewyork
    Conference Program NATIONAL CONFERENCE Treatment & Recovery: People & Outcomes APRIL 25-29,2009 HILTON NEW YORK Joint Sponsors: American Association for the Treatment of Opioid Dependence, Inc. & American Society of Addiction Medicine www.aatod.org Treatment & Recovery: People & Outcomes CONFERENCE PLANNING COMMITTEE 2009 CONFERENCE COMMITTEES Ira J. Marion, MA Conference Chair Awards Committee Mark W. Parrino, MPA Jason Kletter, PhD - Committee Chair President Stacey Pearce American Association for the Treatment of Opioid Dependence, Inc. Michael Rizzi Carleen Maxwell, MPH George Stavros, MD Project Director Jina K. Thalmann, LCSW American Association for the Treatment of Opioid Dependence, Inc. Angelina Budija Hospitality Committee Administrative Coordinator Haynes – Committee Chair American Association for the Treatment of Opioid Dependence, Inc. Dale Wallace-Thompson, MS Alexandra Springer Caroline Waterman, MA Meeting Manager Talley Management Group, Inc. International Committee Wendy Stevens Michael Rizzi – Committee Chair Tradeshow Manager Icro Maremmani, MD Talley Management Group, Inc. Ira J. Marion, MA Mark W. Parrino, MPA Board of Directors Mark W. Parrino, MPA NY Plenary Committee President Herbert Barish, MSW - Committee Chair Ira J. Marion, MA NY Ira J. Marion, MA First Vice-President Robert B. Millman, MD George Stavros, MD AZ Mark W. Parrino, MPA Second Vice President Public Relations Committee Michael Rizzi RI Treasurer Daniel McGill – Committee Chair Jina K. Thalmann, LCSW FL Dianne Henk Secretary Jim Mandler Nancy Moon Board Members Loretta Parsons-Poole Richard Bilangi, MS CT Roye T. Brown, MS LA Volunteer Committee Carol Butler, MA MD Kathryn Williams, LMSW – Committee Chair Brian Crissman, BA DC Felice Bradford Richards, BA Eric Ennis, LCSW CO Celia Harewood, MA Steve Flora AL Marie Marciano, LMSW Richard Froncillo, LCDS PA Glorice Sanders, RN Gregory Hardin, CADACII IN Martin Ringer Edward J.
    [Show full text]
  • Análisis De La Imperialización De Los Territorios En Mesoamérica Y Crítica Al Estado De Sitio Y La Guerra Total Contra Las Poblaciones En El Colapso Mundial
    UNIVERSIDAD NACIONAL DE COSTA RICA FACULTAD DE FILOSOFÍA Y LETRAS ESCUELA DE FILOSOFÍA DOCTORADO EN ESTUDIOS LATINOAMERICANOS CON ÉNFASIS EN PENSAMIENTO LATINOAMERICANO ANÁLISIS DE LA IMPERIALIZACIÓN DE LOS TERRITORIOS EN MESOAMÉRICA Y CRÍTICA AL ESTADO DE SITIO Y LA GUERRA TOTAL CONTRA LAS POBLACIONES EN EL COLAPSO MUNDIAL CANDIDATO A DOCTOR: BRYAN GONZÁLEZ HERNÁNDEZ Heredia, 15 de Junio de 2020 Tesis presentada para optar al grado de Doctor en Estudios Latinoamericanos con Énfasis en Pensamiento Latinoamericano. Cumple con los requisitos establecidos por el Sistema de Estudios de Posgrado de la Universidad Nacional, Heredia, Costa Rica. II MIEMBROS DEL TRIBUNAL EXAMINADOR [Dr. Francisco San Lee Campos] Representante del Consejo Central de Posgrado [Dr. Allan González Estrada] Coordinador a.i. del posgrado [Dr. John Saxe-Fernández] Tutor de tesis [Dr. Juan Olivier Gómez Meza] Miembro del Comité Asesor [Dr. Marcus Abilio Gomes Pereira] Miembro del Comité Asesor [Bryan González Hernández] Sustentante III Hacer comprender a los ciudadanos pasmados que aunque no entren en la guerra, están de todos modos. Comité Invisible del Partido Imaginario, 2015 IV TABLA DE CONTENIDO Resumen IX Abreviaturas X Agradecimientos XV Dedicatoria XIX Introducción 1 Capítulo I. El Problema de investigación: análisis de la imperialización 5 de los territorios en Mesoamérica y crítica al estado de sitio y la guerra total contra las poblaciones en el colapso mundial El problema de investigación 5 Justificación 7 Objetivos 14 Estrategia metodológica 15 Tipo de investigación 17 Fuentes de investigación 17 Ubicación temporal y espacial 17 Herramientas de análisis 21 Capítulo II. De las constelaciones teóricas. Esbozo de un mapa estelar- 26 conceptual para la navegación en contextos abismales.
    [Show full text]
  • Building the Future New Faculty and Newly Tenured Faculty
    BLSLawNotes THE MAGAZINE OF BROOKLYN LAW SCHOOL | SPRING 2014 Building the Future New Faculty and Newly Tenured Faculty BLSLawNotes In Every Issue Vol. 19, No. 1 4 Briefs Editor-in-Chief On Board with Manuel Quintana, Sasha Linney ’11, and Linda S. Harvey Tyler Korff ’12; Expanded Resources for Public Service Office; Assistant Dean for External Affairs Welcoming New Dean of Career Services and Director of Public Safety; Dual J.D./LL.M. Program Offered; Managing Editor Andrea Strong ’94 New Glasser Scholarship Program. Fall Events Recap Class Notes Editor CUBE Launch; Religious Freedom and Equal Treatment Caitlin Monck-Marcellino ’02 Symposium; International Business Law Symposium Director of Alumni Relations Addresses Party Autonomy; Canadian Supreme Court Faculty Notes Editor Justice Abella; and more. Eric Riley Director of Communications 20 Between the Lines Contributors A highlight of the best student notes from Brooklyn Law Andrew Ceppos ’14 School’s scholarly journals. Janeen R. Hall ’15 Tina Herrera 21 Clinic Update Garynn M. Noel ’15 PipS Fellows selected and 2-year placements announced; Erin Ogburn ’13 Andrea Polci Clinical coursework becomes mandatory. Timothy Poodiack ’14 Lauren Price ’15 34 Faculty Highlights Rebecca Richters ’13 Faculty Notes: Professor Neil B. Cohen presented with two Eric Riley lifetime awards; Professor James Fanto named Gerald Baylin Andrea Strong ’94 Peggy Swisher Professor of Law; Professor Norman Poser writes biography of Lord Mansfield. Graphic Design Ron Hester Design & Photography 44 Alumni Update Photographers Alumni of the Year Awards: Gary Rosenberg ’74, Debra Damion Edwards Humphreys ’84, and Hon. Claire Kelly ’93; Celebrating 25 Patrice Gilbert Years of Summer Legal Process; Brooklyn Brewery Tour; Marty Heitner and 1901 Society Relaunched Ron Hester Q&A: Time on his Hands: A Conversation with Will O’Hare Joe Vericker Lon Jacobs ’81, Executive Vice President and General Counsel of Time Inc.
    [Show full text]
  • Harm Reduction, Drug User Health, and the Transformation of Social Policy in New York
    City University of New York (CUNY) CUNY Academic Works All Dissertations, Theses, and Capstone Projects Dissertations, Theses, and Capstone Projects 9-2015 Getting Out of the Ghetto: Harm Reduction, Drug User Health, and the Transformation of Social Policy in New York Rachel Faulkner-Gurstein Graduate Center, City University of New York How does access to this work benefit ou?y Let us know! More information about this work at: https://academicworks.cuny.edu/gc_etds/918 Discover additional works at: https://academicworks.cuny.edu This work is made publicly available by the City University of New York (CUNY). Contact: [email protected] GETTING OUT OF THE GHETTO: HARM REDUCTION, DRUG USER HEALTH, AND THE TRANSFORMATION OF SOCIAL POLICY IN NEW YORK by RACHEL FAULKNER-GURSTEIN A dissertation submitted to the Graduate Faculty in Political Science in partial fulfillment of the requirements for the degree of Doctor of Philosophy, The City University of New York 2015 ©2015 RACHEL FAULKNER-GURSTEIN All Rights Reserved ii This manuscript has been read and accepted for the Graduate Faculty in Political Science to satisfy the dissertation requirement for the degree of Doctor of Philosophy. John Mollenkopf ____________________ _______________________________________ Date Chair of Examining Committee Alyson Cole ____________________ _______________________________________ Date Executive Officer John Mollenkopf _________________________________________________________________ Joe Rollins _________________________________________________________________ Janet Gornick _________________________________________________________________ Supervisory Committee THE CITY UNIVERSITY OF NEW YORK iii Abstract GETTING OUT OF THE GHETTO: HARM REDUCTION, DRUG USER HEALTH AND THE TRANSFORMATION OF SOCIAL POLICY IN NEW YORK by Rachel Faulkner-Gurstein Adviser: Prof. John Mollenkopf This dissertation is a qualitative study of the emergence and evolution of harm reduction drug policies in New York City.
    [Show full text]
  • Regulations Governing Drugs and Performance Enhancers in Sports
    Fordham Intellectual Property, Media and Entertainment Law Journal Volume 12 Volume XII Number 2 Volume XII Book 2 Article 2 2002 Regulations Governing Drugs and Performance Enhancers in Sports Edward Jurith General Counsel, Executive Office of the President, Office of National Drug Control Policy Adolpho A. Birch Labor Relations Counsel, National Football League Management Council Robert Housman General Counsel, Bracewell & Patterson Ronald Klempner Associate Counsel, National Basketball Players Association Follow this and additional works at: https://ir.lawnet.fordham.edu/iplj Part of the Entertainment, Arts, and Sports Law Commons, and the Intellectual Property Law Commons Recommended Citation Edward Jurith, Adolpho A. Birch, Robert Housman, and Ronald Klempner, Regulations Governing Drugs and Performance Enhancers in Sports, 12 Fordham Intell. Prop. Media & Ent. L.J. 337 (2002). Available at: https://ir.lawnet.fordham.edu/iplj/vol12/iss2/2 This Transcript is brought to you for free and open access by FLASH: The Fordham Law Archive of Scholarship and History. It has been accepted for inclusion in Fordham Intellectual Property, Media and Entertainment Law Journal by an authorized editor of FLASH: The Fordham Law Archive of Scholarship and History. For more information, please contact [email protected]. PANEL2.FINAL 2/15/02 2:51 PM Panel II: Regulations Governing Drugs and Performance Enhancers in Sports Moderator: Edward Jurith1 Panelists: Adolpho A. Birch III2 3 Robert Housman 4 Ronald Klempner Maidie Oliveau5 MS. COHEN: Our
    [Show full text]
  • Lowering Expectations Supply Control and the Resilient Cocaine Market
    Lowering Expectations Supply Control and the Resilient Cocaine Market John Walsh, Washington Office on Latin America April 14, 2009 SUMMARY • Data recently made public by the Obama administration show that U.S. cocaine prices continued to fall through 2007, while purity remained high. • The new data undermine well-publicized claims by George W. Bush administration officials that supply disruptions had achieved unprecedented cocaine shortages in the United States. • Cocaine’s annual average U.S. retail price per pure gram in 2007 was the lowest figure on record, nearly 22 percent lower than in 1999, the year before Plan Colombia was launched. • The inability to drive prices higher over this period squares with recent U.S. and UN assessments that Colombian and overall Andean cocaine production has grown. • Fresh claims of market disruptions and cocaine price spikes should be placed in historical perspective; past disruptions have proven temporary. • Helping Mexico to reduce drug-related violence and to improve public safety will not necessarily entail a sustained reduction in the flow of illicit drugs into the United States. • The United States can and should do more to reduce demand for cocaine, but a dramatic reduction in the size of the lucrative U.S. cocaine market should not be expected any time soon. • A realistic and humane drug policy should focus on harm reduction – aiming to minimize the harms caused by illicit drug production, distribution and abuse, but also striving to minimize the damage done by policies meant to control drugs. En route to Mexico in March, Secretary of State Hillary Clinton slammed U.S.
    [Show full text]
  • The Amicus Curiae (Vol. 11, Issue 5)
    College of William & Mary Law School William & Mary Law School Scholarship Repository Student Newspaper (Amicus, Advocate...) Archives and Law School History 2001 The Amicus Curiae (Vol. 11, Issue 5) Repository Citation "The Amicus Curiae (Vol. 11, Issue 5)" (2001). Student Newspaper (Amicus, Advocate...). 351. https://scholarship.law.wm.edu/newspapers/351 Copyright c 2001 by the authors. This article is brought to you by the William & Mary Law School Scholarship Repository. https://scholarship.law.wm.edu/newspapers The VOLUMEXI,ISSUEFIVE TUESDA Y,JANUARY 30,2001 WILLIA..~ & MARY SCHOOL OF LAW Trial Team Takes on the Tar Heels By H. Lee Harrell but far from defeated. Jaron quickly lo­ cated an adequate tie, while Wendy simply Why do they have to win? Why do went around the corner, rotated herself they always have to win. Over the January with arms outstretched, burst briefly into 20"'-2 IstweekendWilliamandMary'sNa­ a ball of flame and emerged in a smartly­ tional Trial Team hosted the University of tailored suit. North Carolina-Chapel Hill s Trial Team in On Sunday, Audra Hale and Wend. the McCandlish Kaine Trial Team Invita­ Roenker defended the now unfairi¥ ac­ tional. cused defendant. The event was sponsored by Despite her prosecutorial bent, Audra McCandlish Kaine, P.c. and Westlaw. marshaled the ~vi dence with skill and gave The trial problem for the tournament an excellent c10siilg statement. Wendy was a criminal theft case. On Saturday was a tigress on cross-examination leav­ William and Mary's team of J aron Chriss ing several witnesses sobbing on the and Wendy Roenker prosecuted the case, stand.
    [Show full text]
  • The United States Government Manual 2000/2001
    The United States Government Manual 2000/2001 Office of the Federal Register National Archives and Records Administration Revised June 1, 2000 Raymond A. Mosley, Director of the Federal Register. John W. Carlin, Archivist of the United States. On the cover: The Washington Monument and the Lincoln Memorial during the restoration of the monument (from the holdings of the National Park Service). In preparation for the bicentennial of the Nation's Capital and the new millennium, the National Park Service embarked on a mission to repair the external damage to the monument caused by weather and time and renovate various systems of the interior of the monument. The monument, which opened to the public in 1888, was erected in honor of the Nation's first President, George Washington, and is the tallest freestanding masonry structure in the world. The restoration project includes repairing the stonework, cleaning the facade, modernizing the heating and cooling systems, improving the elevator, and updating the facilities and refurbishing the exhibits on the observation level. To beautify the monument during its restoration while creating a safe workplace for restoration workers, National Park Service constructors erected scaffolding that, in the words of designer Michael Graves, ``echoes the obelisk's beauty even while covering its exterior.'' For more information on the Washington Monument and its restoration, scheduled for completion in 2000, visit the National Park Service Internet site at www.nps.gov/wamo. Special thanks to Terry J. Adams, Office of Public Affairs, National Park Service for his cooperation and permission to use the photograph of the monument for the cover of the Manual.
    [Show full text]
  • Lowering Expectations Supply Control and the Resilient Cocaine Market
    Lowering Expectations Supply Control and the Resilient Cocaine Market John Walsh, Washington Office on Latin America April 14, 2009 SUMMARY • Data recently made public by the Obama administration show that U.S. cocaine prices continued to fall through 2007, while purity remained high. • The new data undermine well-publicized claims by George W. Bush administration officials that supply disruptions had achieved unprecedented cocaine shortages in the United States. • Cocaine’s annual average U.S. retail price per pure gram in 2007 was the lowest figure on record, nearly 22 percent lower than in 1999, the year before Plan Colombia was launched. • The inability to drive prices higher over this period squares with recent U.S. and UN assessments that Colombian and overall Andean cocaine production has grown. • Fresh claims of market disruptions and cocaine price spikes should be placed in historical perspective; past disruptions have proven temporary. • Helping Mexico to reduce drug-related violence and to improve public safety will not necessarily entail a sustained reduction in the flow of illicit drugs into the United States. • The United States can and should do more to reduce demand for cocaine, but a dramatic reduction in the size of the lucrative U.S. cocaine market should not be expected any time soon. • A realistic and humane drug policy should focus on harm reduction – aiming to minimize the harms caused by illicit drug production, distribution and abuse, but also striving to minimize the damage done by policies meant to control drugs. En route to Mexico in March, Secretary of State Hillary Clinton slammed U.S.
    [Show full text]
  • Does the Constitution Apply to the Actions of the United States Anti-Doping Agency?
    Saint Louis University Law Journal Volume 50 Number 1 (Fall 2005) Article 7 2005 Does the Constitution Apply to the Actions of the United States Anti-Doping Agency? Dionne L. Koller University of Maryland School of Law Follow this and additional works at: https://scholarship.law.slu.edu/lj Part of the Law Commons Recommended Citation Dionne L. Koller, Does the Constitution Apply to the Actions of the United States Anti-Doping Agency?, 50 St. Louis U. L.J. (2005). Available at: https://scholarship.law.slu.edu/lj/vol50/iss1/7 This Symposium is brought to you for free and open access by Scholarship Commons. It has been accepted for inclusion in Saint Louis University Law Journal by an authorized editor of Scholarship Commons. For more information, please contact Susie Lee. SAINT LOUIS UNIVERSITY SCHOOL OF LAW DOES THE CONSTITUTION APPLY TO THE ACTIONS OF THE UNITED STATES ANTI-DOPING AGENCY? DIONNE L. KOLLER* TABLE OF CONTENTS Page I. Introduction ....................................................................................................... 92 II. Background—Why and How USADA Was Created ....................................... 94 A. The Federal Government’s Interest in Drugs and Sports ......................... 94 1. The Federal Government and the USOC ............................................ 94 2. The Fight Against Performance-Enhancing Drug Use in Amateur Sports ................................................................................... 96 3. The National Anti-Doping Strategy .................................................... 98 B. The Government’s Efforts to Establish Domestic and International Anti-Doping Agencies ...................................................... 101 1. The Creation of the World Anti-Doping Agency .............................. 101 2. The Government’s Role in Creating USADA ................................... 105 C. Why USADA’s Designation as a Private Entity is Important ............... 109 III. Does the Constitution Apply to USADA’s Actions? ...................................
    [Show full text]